ABT vs APD · P/E 25, rev $44.33B vs P/E 30, rev $12.04B
Abbott Laboratories (ABT) versus Air Products and Chemicals Inc (APD) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Air Products and Chemicals Inc (APD) is a specialty chemicals company listed on NYSE.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported APD revenue for 2025-09-30 was $12.04B. Net income was -$354.4M. Revenue was down 0.5% from 2024-09-30 to 2025-09-30. APD currently screens at market cap $62.74B and trailing P/E 29.7.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. APD currently screens at market cap $62.74B and trailing P/E 29.7.
Not investment advice. Open the ABT and APD stock pages for the full models.
Not investment advice.